Membrane defence against complement lysis: the structure and biological properties of CD59.
about
Differential role of glycolipid-enriched membrane domains in glycoprotein VI- and integrin-mediated phospholipase Cgamma2 regulation in plateletsComplement and its role in protection and pathogenesis of flavivirus infectionsMolecular and immunological characterization of hr44, a human ocular component immunologically cross-reactive with antigen Ov39 of Onchocerca volvulusTreatment of neuromyelitis optica: state-of-the-art and emerging therapiesThe Caenorhabditis elegans odr-2 gene encodes a novel Ly-6-related protein required for olfactionProduction and characterization of a pig line transgenic for human membrane cofactor protein.AAV-mediated expression of human PRELP inhibits complement activation, choroidal neovascularization and deposition of membrane attack complex in miceApicomplexan perforin-like proteins.PATE, a gene expressed in prostate cancer, normal prostate, and testis, identified by a functional genomic approach.Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59.Identity of the segment of human complement C8 recognized by complement regulatory protein CD59.Complement system in lung disease.Identification of a Naegleria fowleri membrane protein reactive with anti-human CD59 antibody.Aurintricarboxylic acid inhibits complement activation, membrane attack complex, and choroidal neovascularization in a model of macular degeneration.Topical application of PPADS inhibits complement activation and choroidal neovascularization in a model of age-related macular degeneration.CD59a deficiency exacerbates ischemia-reperfusion injury in mice.Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract.Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder.Rapid cycling of lipid raft markers between the cell surface and Golgi complex.Inhibition of the complement membrane attack complex by Schistosoma mansoni paramyosinDeletion of the membrane complement inhibitor CD59a drives age and gender-dependent alterations to bone phenotype in mice.Complement-mediated 'bystander' damage initiates host NLRP3 inflammasome activation.A specific and sensitive assay for blood levels of glycated CD59: a novel biomarker for diabetes.Melanoma cells constitutively release an anchor-positive soluble form of protectin (sCD59) that retains functional activities in homologous complement-mediated cytotoxicity.Lck mediates signal transmission from CD59 to the TCR/CD3 pathway in Jurkat T cells.Anti-Sp17 monoclonal antibody with antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity activities against human ovarian cancer cells.Physiology and pathophysiology of complement: progress and trends.A monoclonal antibody to the rat Crry/p65 antigen, a complement regulatory membrane protein, stimulates adhesion and proliferation of thymocytes.A strategy to ensure safety of stem cell-derived retinal pigment epithelium cells.Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G.Exogenous glycosyl phosphatidylinositol-anchored CD59 associates with kinases in membrane clusters on U937 cells and becomes Ca(2+)-signaling competent.Identification of MIC 11 antigen as an epitope of the CD59 molecule.Chimeras of human complement C9 reveal the site recognized by complement regulatory protein CD59.Trypanosoma cruzi Evades the Complement System as an Efficient Strategy to Survive in the Mammalian Host: The Specific Roles of Host/Parasite Molecules and Trypanosoma cruzi Calreticulin.Tears contain the complement regulator CD59 as well as decay-accelerating factor (DAF).Complement regulatory proteins in kidneys of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.Evolution of cd59 gene in mammals.Developing a microfluidic-based system to quantify cell capture efficiency.Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: tissue distribution and functional comparison.
P2860
Q24534153-C9C9DFF7-6BB5-4273-85A3-5559B5CE670AQ27490236-EEBFACF4-AA76-4910-A8CF-E37143914AD6Q28118109-F9A5084E-E9FF-4A20-90BD-4B0D4FB276B5Q28245749-13CB16C8-71D4-4077-BDCE-9002EA834BFCQ28345584-5FA13011-FAA1-49BD-8C83-71E36637CE47Q31050308-3CD8CEE6-9144-4F66-BA69-2953B2913482Q31154707-6ACE196D-856F-4A90-A94A-29CB1710AEB2Q33895757-4E4F4403-A376-40F3-AF93-B4057CB573E8Q34016309-F039E532-5988-41CB-9AC6-EDA177EA6199Q34173376-06CF6F93-B1DC-470D-8205-68B798190551Q34294347-CFF4C321-C943-4AFA-8123-EF06350BC9CDQ34305533-8FA285B7-5AD1-422E-B293-65EA4B698A53Q34334297-CCE3BD51-3AC0-4BFC-8C9E-F613185A8F93Q35012333-277381AC-D080-4C40-93F0-B9FD8C37EF9FQ35018565-BAADF3B7-7150-4CBF-99F6-E90B7EFBC8E8Q35103059-0A13A4CE-788E-4E4A-AC32-DA553B74FB14Q35350365-FE3CF0A3-88DB-467C-A642-47A64EC44B41Q35782339-EB861198-41B3-4CA1-992B-3CED5B95ED82Q36118869-EB8A9D73-FC7F-4BC4-9441-BA8E5734E0B8Q36360365-B5C438F2-EDF7-4F65-B464-977326DC8B67Q36375634-B1B71853-2E8D-42CA-9784-F803EA8AA915Q36610276-87B1AD2A-AC06-46CD-863D-26A5E140F805Q36970884-5CBBBF47-E692-4F34-8917-B7293A6848F0Q37178439-50F098AF-0CD3-4763-B2B3-90F6A349EB5BQ37372067-E7081AB0-E2A0-4B96-A91D-1AF22B5F4505Q37484364-B424475E-4CC0-43E8-B615-FF84F7FAC3E5Q39422339-0F23AF34-4FD5-4808-9A88-BF5013CB11B5Q40380370-B8AF8C49-533A-4FDD-97FF-8182439D5507Q40863964-0F9692D6-7D71-4A0E-826D-72C92801E8B7Q41010977-3A8DC871-A834-46E0-B55F-2D6E3162ED1DQ41163269-45F1FE4B-62F1-44BC-89A5-65310F3BB912Q41277616-0EE86B3D-5356-4B30-8968-251519BB6A84Q41342401-2FA12134-6122-47B1-A9C9-F7F9237B90C5Q41368231-D6B58689-8029-40CD-9526-F0EED38161A0Q41619655-4E018A32-F2D2-4AA3-B2F2-FE82DBEC5E80Q46219009-372DC476-57DA-45E3-90CE-8133A331C7E1Q47757316-D6DE3F58-6318-4A0C-956D-AA2E0F4A3706Q48077209-420B088D-9C6F-4180-A00D-C29D77575C9CQ50616198-F4641E65-82B1-4DB4-B4C7-47E7955CF044Q51837840-B314BB50-A192-4DB6-91C4-A1C9E644CB27
P2860
Membrane defence against complement lysis: the structure and biological properties of CD59.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Membrane defence against compl ...... biological properties of CD59.
@en
type
label
Membrane defence against compl ...... biological properties of CD59.
@en
prefLabel
Membrane defence against compl ...... biological properties of CD59.
@en
P2860
P356
P1433
P1476
Membrane defence against compl ...... biological properties of CD59.
@en
P2093
P J Lachmann
P2860
P2888
P304
P356
10.1007/BF02918257
P577
1993-01-01T00:00:00Z
P6179
1040800205